Traumatic Brain Injury (TBI), whereby damage to the brain occurs because of a sudden penetrating trauma or closed head injury, affects around 1.7 million people each year in the US alone. Mild TBI is the most common form of brain injury and can cause long term effects and further complications for the patient, but unfortunately it is not easy to diagnose.
With these large numbers of incidents and resulting patient care costs, improved methods are urgently needed for mild TBI diagnosis, recovery monitoring and therapy guidance.
Biomarkers for Traumatic Brain Injury evaluates the current research in this area including eurodegradomics and biomarkers for concussions, astroglial proteins as biomarkers of intracerebral hemorrhage and novel biomarkers of combat TBI.
With contributions from internationally renowned experts, the book is suitable for scientists, pharmacologists, chemists, medical students and graduate students interested in the novel diagnosis and treatment approaches for mild TBI.
Read the latest developments – access the content now!